Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 16.5B | 16.5B | 16.6B | 15.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 78M | -52M | 26M | -9M |
| Other operating expenses | 2.2B | 2.5B | 2.2B | 2.0B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 100M | 101M | 104M | 98M |
| Other income expense | 762M | 801M | 781M | 679M |
| Pretax income | 719M | 2.4B | 1.4B | 430M |
| Tax provision | 123M | 559M | 254M | 83M |
| Net income | 596M | 1.9B | 1.2B | 347M |
| Basic EPS | — | 7.2 | 4.4 | 1.1 |
| Diluted EPS | — | 7.1 | 4.3 | 1.1 |
| Basic average shares | — | 265.1M | 264.6M | 264.1M |
| Diluted average shares | — | 268.7M | 268M | 267.1M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 596M | 1.9B | 1.2B | 347M |
| Minority interests | -1M | 38M | 26M | -16M |
| Preferred stock dividends | — | — | — | — |